Bank of New York Mellon Corp - BELLEROPHON THERAPEUTICS INC ownership

BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 30 filers reported holding BELLEROPHON THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$60,000
-26.8%
170,6720.0%0.00%
Q3 2019$82,000
-19.6%
170,6720.0%0.00%
Q2 2019$102,000
-10.5%
170,672
-2.4%
0.00%
Q1 2019$114,000
-18.6%
174,874
-0.0%
0.00%
Q4 2018$140,000
-25.9%
174,9020.0%0.00%
Q3 2018$189,000
-55.3%
174,9020.0%0.00%
Q2 2018$423,000
+15.3%
174,902
-0.7%
0.00%
Q1 2018$367,000
-19.9%
176,117
-0.7%
0.00%
Q4 2017$458,000177,4290.00%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Puissance Capital Management LP 8,298,755$8,963,0006.26%
VHCP Management III, LLC 2,274,370$2,456,0001.86%
VHCP Management II, LLC 4,149,378$4,481,0001.20%
NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. 15,138,486$16,350,0001.18%
Boxer Capital, LLC 1,482,143$1,601,0000.18%
Telemetry Investments, L.L.C. 67,660$73,0000.03%
Virtu Financial LLC 22,909$25,0000.00%
GABLES CAPITAL MANAGEMENT INC. 1,400$2,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 123,000$133,0000.00%
SeaCrest Wealth Management, LLC 3,000$3,0000.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders